Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women
Status:
Withdrawn
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The specific purpose of this study is to provide objective data in prospective open label
design (n=40) to support the use of Mirabegron as a treatment for pain related urinary
frequency and urgency. Women with bladder pain have a poor response to traditional
anticholinergic therapy for their symptoms of frequency and urgency.